Atlas Trials

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer

Clinical trial NCT07427186 · RECRUITING

Trial details

NCT number
NCT07427186
Sponsor
Institut Claudius Regaud
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Solid Cancers
Start date
2026-08-06
Primary completion
2041-08-06
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.